Latest News - Cynosure

Wednesday, September 27, 2017 | FDA Approval/Clearance, PracticalDermatology.com, Cynosure

Sculpsure Cleared to Treat Double Chins

Cynosure's SculpSure®  is now cleared for submental fat reduction. The U.S. Food and Drug Administration (FDA) granted an expanded FDA 510(k) clearance for this area, Hologic, Inc. rep…

Read the full story

Thursday, June 15, 2017 | FDA Approval/Clearance, PracticalDermatology.com, Cynosure

Cynosure's SculpSure Cleared for Back, Inner and Outer Thighs

The U.S. Food and Drug Administration (FDA) granted an expanded clearance for Cynosure's SculpSure to treat the back and inner and outer thighs. The SculpSure treatment is already FDA-clea…

Read the full story

Tuesday, February 14, 2017 | Acquisitions and Mergers, PracticalDermatology.com, Allergan , Cool Sculpting, Cynosure, PicoWay, Profound, Syneron, Tattoo , Zeltiq

Rumor Has It Syneron Is Next In Week of Surprising Aquisitions

Hot off the heels of Allergan’s acquisition of Zeltiq and Hologic Inc,’s surprising purchase of Cynosure Inc., media reports are now swirling that British private equity fund Apax Partners…

Read the full story

Tuesday, February 14, 2017 | Acquisitions and Mergers, Personnel/Company News, PracticalDermatology.com, Cosmetic surgery, Cynosure

Hologic to Acquire Cynosure

Hologic, Inc.  and Cynosure, Inc. have signed a definitive agreement for Hologic to acquire all outstanding Cynosure shares for $66.00 per share in cash, which corresponds to an eq…

Read the full story

Tuesday, September 13, 2016 | Personnel/Company News, Cynosure

Cynosure to Name Stephen J. Webber as New CFO

Cynosure, Inc. announced that Stephen J. Webber will join the company on October 10, 2016 as Executive Vice President. Mr. Webber will then become Chief Financial Officer and Chief Accounting Officer …

Read the full story

Wednesday, August 10, 2016 | PracticalDermatology.com, Practice Development, Cynosure, Merz, Syneron, Zeltiq

Men, New Technologies Drive Growth in Body Contouring Market

The body contouring market is set to rise from $671.8 million in 2015 to more than $1.1 billion by 2022, representing a compound annual growth rate of 7.9%, according to research and consulting firm G…

Read the full story

Wednesday, July 13, 2016 | FDA Approval/Clearance, PracticalDermatology.com, Cynosure

Cynosure Receives Health Canada Authorization to Market SculpSureĀ®

Cynosure, Inc. received Health Canada Authorization to Market SculpSure® for non-invasive lipolysis of the abdomen and flanks. SculpSure is a fat-reduction laser intended for individuals with a…

Read the full story

Tuesday, May 24, 2016 | FDA Approval/Clearance, PracticalDermatology.com, Cynosure

Cynosure Receives FDA Clearance to Market PicoSure Energy Delivery System for Tattoos and Pigmented Lesions

The FDA granted clearance to Cynosure to market a new Laser Delivery System for PicoSure. Together with the FDA cleared 532nm and 755nm wavelengths, Cynosure's new 1064nm Laser Delivery System imp…

Read the full story

Tuesday, March 29, 2016 | PracticalDermatology.com, PracticalDermatology.com, PracticalDermatology.com, PracticalDermatology.com, Research and Publications, Cynosure, Lutronics, Merz, Syneron

North America's Scar Treatment Poised for Growth Spurt by 2022

Scar treatment will be a hot growth area in coming years, according to a new report by Persistence Market Research. The report cites a rising incidence of burn and trauma cases and an increasi…

Read the full story

Friday, September 04, 2015 | PracticalDermatology.com, Product Launches and Updates, Cynosure

Cynosure to Host Investor Event to Introduce SculpSure

Cynosure, Inc. will host an investor event in New York City on Tuesday, September 15 to introduce SculpSure™, the only FDA-cleared hyperthermic laser treatment for non-invasive fat reduction. Th…

Read the full story

Tuesday, July 07, 2015 | FDA Approval/Clearance, PracticalDermatology.com, Cynosure

Cynosure's SculpSure Receives Expanded FDA Clearance for Lipolysis of the Abdomen

Cynosure, Inc. has received 510(k) clearance from the FDA to market SculpSure™ for non-invasive lipolysis of the abdomen. In May, the FDA cleared SculpSure for non-invasive lipolysis of the flan…

Read the full story

Tuesday, February 24, 2015 | FDA Approval/Clearance, PracticalDermatology.com, Cynosure

FDA Clears New 532 nm Laser Delivery System for PicoSure from Cynosure

Cynosure, Inc. received FDA 510(k) clearance of its new 532 nm Laser Delivery System for PicoSure®, creating a powerful, dual-wavelength laser system for removing tattoos of all colors in fewer tr…

Read the full story